The increased TXLNA expression group had favourable OS in PAAD patients with alcohol history (p=0.0454; HR: 0.5088; 95% CI: 0.2625–0.9861; Figure 3(g)), but not in PAAD patients with no-alcohol history (p=0.1046; HR: 0.5048; 95% CI: 0.2211–1.1525; Figure 3(h)). The gene discussed is TXLNA; the disease is pancreatic adenocarcinoma.